-

$undefined

N/A

(N/A)

Aura Biosciences Inc NASDAQ:AURA

Location: | Industry: Research and Development in Biotechnology | Sector: Professional, Scientific, and Technical Services

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

264.2M

Cash

187.4M

Avg Qtr Burn

-18.34M

Short % of Float

3.85%

Insider Ownership

5.08%

Institutional Own.

80.16%

Qtr Updated

06/30/24

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Belzupacap Sarotalocan (Bel-sar) Details Primary Choroidal Melanoma	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Belzupacap Sarotalocan (Bel-sar) (Suprachoroidal (SC) Administration) Details Primary Choroidal Melanoma	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Belzupacap Sarotalocan (Bel-sar) Details Non-muscle invasive bladder cancer, Muscle-invasive bladder cancer	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.